Alpa M. Nick

11.3k total citations · 2 hit papers
146 papers, 5.7k citations indexed

About

Alpa M. Nick is a scholar working on Molecular Biology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Alpa M. Nick has authored 146 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 42 papers in Reproductive Medicine and 38 papers in Obstetrics and Gynecology. Recurrent topics in Alpa M. Nick's work include Ovarian cancer diagnosis and treatment (37 papers), Endometrial and Cervical Cancer Treatments (37 papers) and Angiogenesis and VEGF in Cancer (22 papers). Alpa M. Nick is often cited by papers focused on Ovarian cancer diagnosis and treatment (37 papers), Endometrial and Cervical Cancer Treatments (37 papers) and Angiogenesis and VEGF in Cancer (22 papers). Alpa M. Nick collaborates with scholars based in United States, Brazil and South Korea. Alpa M. Nick's co-authors include Anil K. Sood, Pedro T. Ramírez, Robert L. Coleman, Kathleen M. Schmeler, Rebecca L. Stone, Pamela T. Soliman, Larissa A. Meyer, Michael Frumovitz, Gabriel Lopez‐Berestein and Yvonne G. Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Alpa M. Nick

140 papers receiving 5.6k citations

Hit Papers

Guidelines for postoperative care in gynecologic/oncology... 2015 2026 2018 2022 2016 2015 100 200 300 400

Peers

Alpa M. Nick
Rebecca L. Stone United States
Mijin Yun South Korea
Koen DeGeest United States
Jeong‐Won Lee South Korea
Rebecca L. Stone United States
Alpa M. Nick
Citations per year, relative to Alpa M. Nick Alpa M. Nick (= 1×) peers Rebecca L. Stone

Countries citing papers authored by Alpa M. Nick

Since Specialization
Citations

This map shows the geographic impact of Alpa M. Nick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alpa M. Nick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alpa M. Nick more than expected).

Fields of papers citing papers by Alpa M. Nick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alpa M. Nick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alpa M. Nick. The network helps show where Alpa M. Nick may publish in the future.

Co-authorship network of co-authors of Alpa M. Nick

This figure shows the co-authorship network connecting the top 25 collaborators of Alpa M. Nick. A scholar is included among the top collaborators of Alpa M. Nick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alpa M. Nick. Alpa M. Nick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wittayer, Matthias, Margarida Dias, Alpa M. Nick, et al.. (2023). Clinical Features and Voxel-Based-Symptom-Lesion Mapping of Silent Aspiration in Acute Infratentorial Stroke. Dysphagia. 39(2). 289–298. 1 indexed citations
2.
Ahmed, Jibran, Bettzy Stephen, Ece Kılıç, et al.. (2023). Abstract A121: Temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer. Molecular Cancer Therapeutics. 22(12_Supplement). A121–A121. 1 indexed citations
3.
Mitra, Aparna, Kyoko Yoshida-Court, Travis Solley, et al.. (2021). Extracellular vesicles derived from ascitic fluid enhance growth and migration of ovarian cancer cells. Scientific Reports. 11(1). 9149–9149. 21 indexed citations
4.
Fleming, Nicole D., Alpa M. Nick, Robert L. Coleman, et al.. (2018). Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer. Obstetrics and Gynecology. 132(3). 545–554. 36 indexed citations
5.
Huang, Jie, Wei Hu, Limin Hu, et al.. (2016). Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth. Molecular Cancer Therapeutics. 15(6). 1344–1352. 41 indexed citations
6.
Previs, Rebecca A., Guillermo N. Armaiz-Peña, Yvonne G. Lin, et al.. (2015). Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer. Molecular Cancer Therapeutics. 14(12). 2677–2686. 11 indexed citations
7.
Wen, Yunfei, Whitney A. Spannuth Graybill, Rebecca A. Previs, et al.. (2014). Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer. Clinical Cancer Research. 21(2). 448–459. 53 indexed citations
8.
Bottsford-Miller, Justin, Hyun Jin Choi, Heather J. Dalton, et al.. (2014). Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer. Clinical Cancer Research. 21(3). 602–610. 73 indexed citations
9.
Tucker, Susan L., Kshipra M. Gharpure, Shelley M. Herbrich, et al.. (2014). Molecular Biomarkers of Residual Disease after Surgical Debulking of High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 20(12). 3280–3288. 68 indexed citations
10.
You, Jian, Rui Zhang, Chiyi Xiong, et al.. (2012). Effective Photothermal Chemotherapy Using Doxorubicin-Loaded Gold Nanospheres That Target EphB4 Receptors in Tumors. Cancer Research. 72(18). 4777–4786. 164 indexed citations
11.
Ivan, Cristina, Wei Hu, Justin Bottsford-Miller, et al.. (2012). Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer. Gynecologic Oncology. 128(3). 506–511. 32 indexed citations
12.
Kim, Hye‐Sun, Hee Dong Han, Guillermo N. Armaiz-Peña, et al.. (2011). Functional Roles of Src and Fgr in Ovarian Carcinoma. Clinical Cancer Research. 17(7). 1713–1721. 62 indexed citations
13.
Pecot, Chad V., Farideh Z. Bischoff, Julie Ann Mayer, et al.. (2011). A Novel Platform for Detection of CK+ and CK− CTCs. Cancer Discovery. 1(7). 580–586. 160 indexed citations
14.
Spannuth, Whitney A., Lingegowda S. Mangala, Rebecca L. Stone, et al.. (2010). Converging Evidence for Efficacy from Parallel EphB4-Targeted Approaches in Ovarian Carcinoma. Molecular Cancer Therapeutics. 9(8). 2377–2388. 33 indexed citations
15.
Han, Hee Dong, Lingegowda S. Mangala, Jeong Won Lee, et al.. (2010). Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles. Clinical Cancer Research. 16(15). 3910–3922. 202 indexed citations
16.
Lee, Jeong‐Won, Rebecca L. Stone, Sun Joo Lee, et al.. (2010). EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma. Clinical Cancer Research. 16(9). 2562–2570. 57 indexed citations
17.
Merritt, William M., Alpa M. Nick, Amy R. Carroll, et al.. (2010). Bridging the Gap between Cytotoxic and Biologic Therapy with Metronomic Topotecan and Pazopanib in Ovarian Cancer. Molecular Cancer Therapeutics. 9(4). 985–995. 47 indexed citations
18.
Landen, Charles N., Blake W. Goodman, Ashwini A. Katre, et al.. (2010). Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer. Molecular Cancer Therapeutics. 9(12). 3186–3199. 322 indexed citations
19.
Lin, Yvonne G., Anand Immaneni, William M. Merritt, et al.. (2008). Targeting Aurora Kinase with MK-0457 Inhibits Ovarian Cancer Growth. Clinical Cancer Research. 14(17). 5437–5446. 51 indexed citations
20.
Mangala, Lingegowda S., Jansina Y. Fok, Yvonne G. Lin, et al.. (2008). Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma. Cancer Research. 68(14). 5849–5858. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026